中基長壽科學(00767.HK)擬1260萬港元收購榮星置業全部股權
格隆匯2月21日丨中基長壽科學(00767.HK)發佈公吿,2022年2月18日,傑迅控股有限公司(公司的直接全資附屬公司)作為買方與賣方遊經國先生訂立收購協議,據此,賣方同意出售目標公司榮星置業有限公司全部已發行股本及股東貸款,總現金代價為1260萬港元。
目標公司為放債人條例下一名香港持牌放債人,主要從事放債業務,自2018年開始在香港進行業務,主要提供無抵押貸款予香港創新科技署推出的科技券計劃下的成功中小企申請人;按揭貸款;及無抵押個人貸款或汽車融資貸款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.